Asset Allocation

As of January 31, 2025.
Type % Net
Cash 2.75%
Stock 63.71%
Bond 33.41%
Convertible 0.00%
Preferred 0.00%
Other 0.13%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2025
Large 84.36%
Mid 10.35%
Small 5.29%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.84%    % Emerging Markets: 0.00%    % Unidentified Markets: 0.16%

Americas 94.52%
94.17%
Canada 1.29%
United States 92.89%
0.34%
As of January 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.67%
United Kingdom 0.88%
2.79%
Denmark 0.08%
France 0.69%
Ireland 0.81%
Italy 0.06%
Netherlands 0.11%
Norway 0.03%
Spain 0.29%
Switzerland 0.31%
0.00%
0.00%
Greater Asia 1.65%
Japan 0.00%
0.18%
Australia 0.18%
1.47%
Hong Kong 0.31%
Singapore 1.14%
0.00%
Unidentified Region 0.16%

Bond Credit Quality Exposure

AAA 0.14%
AA 49.20%
A 8.36%
BBB 28.20%
BB 2.41%
B 0.05%
Below B 0.03%
    CCC 0.00%
    CC 0.03%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 11.59%
Short Term 0.00%
As of January 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
20.80%
Materials
3.60%
Consumer Discretionary
6.98%
Financials
9.24%
Real Estate
0.99%
Sensitive
54.17%
Communication Services
9.52%
Energy
4.34%
Industrials
7.28%
Information Technology
33.03%
Defensive
20.55%
Consumer Staples
5.84%
Health Care
12.09%
Utilities
2.62%
Not Classified
4.48%
Non Classified Equity
4.48%
Not Classified - Non Equity
0.00%
As of June 30, 2024
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2025
Type % Net
Government 39.78%
Corporate 40.54%
Securitized 18.27%
Municipal 0.13%
Other 1.29%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.11%
Less than 1 Year
1.11%
Intermediate
58.67%
1 to 3 Years
12.82%
3 to 5 Years
24.75%
5 to 10 Years
21.10%
Long Term
39.83%
10 to 20 Years
6.48%
20 to 30 Years
32.12%
Over 30 Years
1.22%
Other
0.39%
As of January 31, 2025
View Bond Maturity Exposure
Start Trial